The Trump administration is desperately rushing to market an unproven (and possibly unsafe) vaccine for October. The Administration hopes the vaccine will help Trump’s reelection. Researchers have an incomplete understanding of the coronavirus and are using technology that’s largely unproven. Experts are worried that it won’t be safe. Many worry that regulators will give emergency approval to an unsafe vaccine before the November election.
“We expect to have a vaccine available very, very early before the end of the year, far ahead of schedule,” Trump said last month. “We’re very close to having that finalized.” That is clearly not true. Nor will it be available immediately to the general public. Dr. Fauci told MarketWatch that frontline health workers should be first in line to get a vaccine.
Pushing an unsafe vaccine will not help his pandemic response. It may reduce people’s faith in a vaccine. We may spend years perfecting the vaccines and drugs that will handle it most effectively. Experts admit that a vaccine will be the beginning of dealing with the coronavirus not the end.
Cyrus R. Vance Jr is the Manhattan district attorney. He finally admitted that a criminal investigation into Trump and his company for possible bank and insurance fraud exists. Trump does a lot of business in Europe with Russian oligarchs.
Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States. The two European companies have close ties to Trump allies and henchman. The United States will pay more than $2.1 billion “for development including clinical trials, manufacturing, scale-up and delivery” of the vaccine. Sanofi will get the bulk of the funds. Why isn’t our taxpayer money going to European corporations instead of American? What happened to America First?